Skip to main content
The University of Arizona Wordmark Line Logo White
Stories & Features Announcements Calendar Leadership Updates Event Planning Room Scheduling Café Bolo Directories IT Support Classroom Support Planning & Facilities
The University of Arizona Health Sciences | Home
Subscribe
Support
home home

Main navigation

  • Overview Senior Leadership Academic Leadership Executive Leadership Annual Report Mission, Values, History Support
  • Overview College of Health Sciences College of Medicine – Phoenix College of Medicine – Tucson College of Nursing Mel and Enid Zuckerman College of Public Health R. Ken Coit College of Pharmacy
  • Research Administration Research Awards and Grants
  • Clinical
  • Overview Community Engagement Alliance Corporate and Community Relations Health and Humanities Rural Health Student Engagement and Career Advancement
  • Overview Aegis Consortium All of Us Research Program Arizona Area Health Education Centers Arizona Simulation Technology & Education Center Asthma & Airway Disease Research Center Center for Accelerated Biomedical Innovation Center for Advanced Molecular & Immunological Therapies Center for Biomedical Informatics & Biostatistics Center for Disparities in Diabetes, Obesity & Metabolism Center for Innovation in Brain Science Center for Sleep, Circadian & Neuroscience Research Clinical & Translational Sciences Research Center Comprehensive Center for Pain & Addiction Health Sciences SensorLab One Health University of Arizona Cancer Center
  • All News Stories Videos The Healthy Dose Blog News Releases In The Media Media Resources Office of Communications
  1. Home
  2. News
  3. Study Seeks Transform Methadone Treatment Opioid Use Disorder

Trump Touts Antibody Treatments for COVID-19, but Evidence Is Incomplete

Oct. 8, 2020

President Donald Trump continues to tout an experimental treatment he received for COVID-19 as a cure for the disease despite an absence of evidence to back up that claim. Immunobiologist Deepta Bhattacharya at the University of Arizona College of Medicine - Tucson said there's a theoretical chance the treatment could prevent people from developing their own immunity. The monoclonal antibodies may block the part of the virus that the immune system needs to "see" to develop protective immunity. If that's the case, the immune system wouldn't develop its own longer-lasting antibodies.

NPR

U of a Researchers Say COVID-19 Can Give a False Sense of Pain Relief

Oct. 8, 2020

The University of Arizona researchers have discovered that COVID-19 can give a false sense of pain relief. Many people with COVID-19 don’t show symptoms right away or are asymptomatic entirely, which sparked the interest of researchers at the U of A.

KOLD-TV (CBS) Tucson

Talk 980 (KMBZ): Migraines and Green Light Therapy

Oct. 8, 2020

Research from the University of Arizona Health Sciences found that people who suffer from migraines may benefit from something called green light therapy which is exactly what it sounds like. Listeners call in to the live Dana & Parks Show and share their experience living with migraines.

KMBZ-AM (Kansas City, MO)

Does Coronavirus BLOCK Pain? Study Suggests It Could Act Like a Painkiller to Mask Illness in the Early Stages as the Virus Spreads Throughout the Body

Oct. 8, 2020

The novel coronavirus may be able to block pain and mask the illness in its early stages as it spreads throughout the body, a new study suggests. The team, from the University of Arizona Health Sciences, says the findings may explain why nearly half of all patients with COVID-19 experience no symptoms.

Daily Mail (UK)

Cancer and COVID-19: How the Novel Coronavirus Is Affecting Screening and Treatment

Oct. 8, 2020

Julie Bauman is an oncologist and the deputy director of the University of Arizona Cancer Center. As a specialist who works with cancer patients every day, she understands their unique vulnerability to COVID-19. Due to this increased risk, doctors at the UA Cancer Center noticed a decrease in patients coming in for preventive screenings at the height of the pandemic, resulting in an increase in advanced cases arriving at the cancer center as the number of coronavirus cases declines.

Tucson Weekly
Image

NIH New Innovator Award to Fund UArizona Health Sciences Research on Opioid Addiction and Relapse in Postpartum Women

Oct. 7, 2020

The $2.3 million National Institutes of Health grant will enable Dr. Alicia Allen to explore how women’s hormones influence postpartum opioid relapse and if they may be used as a preventative strategy.

Read more

Study Confirms Genetic Link in Cerebral Palsy

Oct. 7, 2020

An international research team has found further evidence that rare gene mutations can cause cerebral palsy, findings which could lead to earlier diagnosis and new treatments for this devastating movement disorder. Michael Kruer, a neurogeneticist at Phoenix Children’s Hospital and the University of Arizona College of Medicine – Phoenix, is senior author of the study.

Health News Digest

President, Said to Be Symptom-Free, Tries to Return to Business as Normal

Oct. 7, 2020

President Trump is described as symptom-free, but experts question the significance of his antibody test results. Dr. Deepta Bhattacharya, an immunologist at the University of Arizona College of Medicine said the results shared by White House physician Dr. Sean P. Conley wouldn’t shed much light on Mr. Trump’s condition. “The way that it’s implied is that he’s made a normal immune response, but I don’t see how you would be able to tell the difference.”

New York Times

Coronavirus: Trump Reports ‘No Symptoms’ yet COVID-19 Shown to Dull the Senses

Oct. 7, 2020

Coronavirus could go on undetected for some people. As the President of America reportedly has 'no symptoms' after falling ill, scientists discover how the disease may dull the senses. In October 2020, researchers from the University of Arizona Health Sciences revealed coronavirus is capable of dulling pain pathways. The study is published in the journal Pain.

Daily Express (UK)

Many Non-Hodgkin's Lymphoma Patients Can Skip Radiation, Collaborative Study Finds

Oct. 7, 2020

Skipping radiation and receiving less chemotherapy may become the new standard of care for some lymphoma patients, according to a recent collaborative study led by a Daniel Persky, MD, associate director for clinical investigations at the UArizona Cancer Center.

Medical Xpress

Pagination

  • « First First page
  • ‹ Previous Previous page
  • …
  • 470
  • 471
  • 472
  • 473
  • 474
  • 475
  • 476
  • 477
  • 478
  • …
  • Next › Next page
  • Last » Last page
The University of Arizona Health Sciences | Home

Health Sciences

  • About
  • Academics
  • Clinical Care
  • Outreach

News

  • Stories
  • Healthy Dose Blog
  • News Releases
  • In The Media
  • Media Resources
  • Videos

Internal Resources

  • Stories & Features
  • Announcements
  • Calendar
  • Leadership Updates
  • Honors and Awards
  • Event Planning
  • Room Scheduling
  • Café Bolo
  • El Mirador Project
  • IT Support
  • Classroom Support
  • Planning and Facilities
  • Photo Galleries
  • Directories

Connect

  • Facebook
  • YouTube
  • Instagram
  • LinkedIn
  • X, formerly Twitter

We respectfully acknowledge the University of Arizona is on the land and territories of Indigenous peoples. Today, Arizona is home to 22 federally recognized tribes, with Tucson being home to the O’odham and the Yaqui. The University strives to build sustainable relationships with sovereign Native Nations and Indigenous communities through education offerings, partnerships, and community service.


University Information Security and Privacy

© 2025 The Arizona Board of Regents on behalf of The University of Arizona.